Ro (Ro Body Program)
Provider Profile Name: Ro (Ro Body Program)
Website: ro.co
Formerly known as: Roman
Provider Type: Multi-Condition Telehealth Platform — Ro Body is the Weight Management Program
Operating Details
- Fully virtual — online health questionnaire, licensed provider review, app-based ongoing care
- Ro Body membership: $45 for the first month, $145/month ongoing — medication cost billed separately
- FDA-approved GLP-1 medications’ primary offering; compounded semaglutide available in some states as a fallback
- Insurance accepted for brand-name GLP-1 medications; membership itself is cash-pay only
- Insurance concierge fights for prior authorization coverage and manages all paperwork on behalf of patients; if insurance denies coverage, cash-pay alternatives are offered
- Labs included in membership — Quest Diagnostics locations or at-home kit ($75) if Quest is unavailable in the patient’s state
- Weekly nurse coaching is included in membership
- 24/7 provider messaging access
- Injectable medications only for GLP-1 programs — no oral lozenge or drop formats
- 3,131 Trustpilot reviews
Approach From personalized treatment to insurance support, Ro helps patients get and stay on track, with a provider reviewing answers and determining whether treatment may be right for them before prescriptions are issued. Ro’s differentiating claim relative to most competitors in this review series is its positioning around FDA-approved brand-name medications with integrated insurance navigation — rather than leading with compounded GLP-1 price points.
About the Company
Ro is a telehealth platform formerly known as Roman that offers products and services designed to address a wide range of health concerns, including weight loss, hair loss, erectile dysfunction, fertility, and more. Ro Body is the weight management sub-brand, launched to capitalize on GLP-1 demand while leveraging the company’s existing telehealth infrastructure and licensed provider network.
The company’s model is distinctly more clinician-integrated than most compounded GLP-1 platforms in this series. The Ro Body Program includes FDA-approved GLP-1s like Wegovy, Ozempic, and Zepbound, as well as compounded options in some states if insurance won’t cover the brand names, alongside lab testing, one-on-one nurse coaching, and direct provider access, everything managed through a single app.
Ro’s insurance navigation infrastructure is a key differentiator. If a provider orders a metabolic health test, testing at any Quest location is included in the cost of the Ro Body membership. For patients with insurance that covers GLP-1s for weight loss, Ro’s prior authorization handling, which can take two to three weeks, can unlock brand-name access at copay pricing well below what any compounded alternative offers.
GLP-1 Offerings and Weight Loss Services
Ro’s primary medication menu is FDA-approved brand-name GLP-1s, with compounded semaglutide available as a state-dependent secondary option:
FDA-Approved GLP-1 Injectables:
- Wegovy (semaglutide) — available as a pen, pill, and cash-pay vial options; Zepbound (tirzepatide) — available as a pen or vial (cash-pay)
- Ozempic (semaglutide) — FDA-approved for Type 2 diabetes, may be prescribed off-label for weight loss; Saxenda (liraglutide)
Compounded Options (state-dependent):
- Ro offers compounded semaglutide in some states, but these products are not FDA-approved and may vary in formulation or purity generally offered only when FDA-approved products are unavailable or insurance won’t cover them
- Ro also offers “Sparks” and “Daily Rise Gummies” compounded medications that are not FDA-approved and do not undergo FDA safety, effectiveness, or manufacturing review
Included in Ro Body Membership:
- Lab testing, one-on-one weekly nurse coaching, ongoing care including dose monitoring and messaging, and tools for lifestyle change, all managed through a single app
- Insurance concierge service for prior authorization
- Medication ready in less than a week if paying cash; two to three weeks if using insurance with prior authorization
Pricing — and What Reviewers Say
Ro’s pricing structure separates membership from medication, a model that can be advantageous for insured patients but adds complexity for cash-pay patients:
Membership:
- $45 for the first month, then $145/month ongoing; membership does not include medication cost
Cash-Pay Medication Options:
- Wegovy pill: from $149/month (1.5mg dose); $199/month for 4mg through April 15, 2026, then $199/month; $299/month for 9mg and 25mg, ongoing $145/month membership required
- Wegovy pen: $199/month introductory for the first two months (0.25mg and 0.5mg doses only) through March 31, 2026, then $349/month for all higher doses, ongoing $145/month membership required
- Zepbound vial: from $299/month (2.5mg), $399/month (5mg), and $449/month for the 7.5, 10, 12.5, and 15mg doses, ongoing $145/month membership required
With Insurance:
- Medication cost depends on plan coverage and copay; Ro’s insurance concierge handles prior authorization and submits all paperwork. If covered, the prescription is sent to the patient’s pharmacy
What reviewers say about pricing: The membership-plus-medication structure is the most consistent source of pricing friction in Ro’s review pool. Multiple reviewers describe a bait-and-switch pattern, being given an introductory offer on medication without being clearly told upfront about the $145/month ongoing membership fee, which compounds on top of medication costs. The effective all-in cash-pay cost membership plus medication is meaningfully higher than most compounded GLP-1 platforms in this review series: a patient on Wegovy pen at the $349/month ongoing rate pays $494/month total with the membership included, before any labs or consultations. Some reviewers explicitly note that other suppliers offer similar services at lower total costs, citing the combined membership and medication pricing as not competitive with compounded alternatives.
That said, for insured patients who successfully obtain prior authorization for brand-name Wegovy or Zepbound, the math flips; a $25–$50/month insurance copay plus a $145/month membership ($170–$195/month total) is among the most cost-efficient paths to brand-name, FDA-approved GLP-1 treatment in this review series. Ro’s value proposition is strongest for patients with qualifying insurance; weakest for uninsured cash-pay patients, comparing on price alone.
Reviews from Trustpilot and Google
Ro has 3,131 Trustpilot reviews at the time of writing, a meaningful review pool that covers both positive experiences and a documented pattern of complaints.
What patients praise:
- Provider communication and ongoing support are praised consistently. Members describe providers as accessible, responsive, and genuinely engaged with weight loss progress rather than simply processing prescriptions
- Insurance navigation is specifically cited as a meaningful benefit; multiple reviewers note they were not expecting the insurance support and were relieved to not have to fight for their coverage themselves
- App-based convenience single platform for provider communication, lab results, coaching, and medication management
- Weight loss results were described positively across a substantial portion of the review pool
Common complaints:
- Pricing transparency, the membership fee presented alongside discounted medication offers, leads to sticker shock when the full ongoing cost becomes clear after the first month
- Some reviewers report being charged before knowing whether they were approved for treatment, and express frustration at the pre-payment model
- Patients seeking oral non-injectable GLP-1 formats report being offered only injectables or compounded compounds despite seeing advertising for oral options, Ro does not offer oral lozenges, drops, or sublingual formats beyond the Wegovy pill
- Some reviewers report zero contact with a medical professional, indicating variability in the clinical engagement experience across different state requirements and provider assignments
Compounding Pharmacies Used
Ro offers compounded semaglutide in some states as a fallback option when FDA-approved products are unavailable, or insurance won’t cover brand-name medications. Specific pharmacy partners for compounded products are not publicly disclosed. For brand-name medications through insurance, prescriptions are sent to the patient’s pharmacy of record. For Zepbound vials and Wegovy at cash-pay prices, Ro aligns pricing with LillyDirect and NovoCare manufacturer programs, meaning the medication flows through manufacturer-authorized fulfillment rather than third-party compounding pharmacies.
Note: Ro Body is a well-established telehealth platform with strong insurance navigation infrastructure and a comprehensive included feature set — labs, weekly coaching, and app-based ongoing care bundled into one membership. Its primary value is strongest for insured patients seeking brand-name FDA-approved GLP-1 access with hands-on prior authorization support. Cash-pay patients will find the combined membership plus medication cost ($295–$494/month at common doses) higher than most compounded GLP-1 alternatives in this directory. The membership-before-eligibility billing model and pricing transparency concerns are the platform’s most documented friction points. Compounded semaglutide is available in some states as a secondary offering — not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.





